¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ 2023 Ãá°è½ÉÆ÷Áö¾ö(2ÀÏÂ÷) : 2023-04-28

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ 2023 Ãá°è½ÉÆ÷Áö¾ö(2ÀÏÂ÷) : 2023-04-28
±³À°ÀÏÀÚ : 2023-04-28
±³À°Àå¼Ò : BEXCO

±³À°ÁÖÁ¦ : ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ 2023 Ãá°è½ÉÆ÷Áö¾ö(2ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ
´ã´çÀÚ : ±èÈñ¼ø
¿¬¶ôó : 070-4436-3303  

À̸ÞÀÏ : kscp3@kams.or.kr

±³À°Á¾·ù : Áø´Ü°Ë»çÀÇÇаú

Âü¼®¿¹»óÀÎ : 1000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡ (ÀÏ¹Ý 4Á¡ / Çʼö 2Á¡)

Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 18 ½Ã°£ 10ºÐ

¼¼ºÎ¼ö°­·á : 250,000¿ø  

ºñ°í

±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room A (1Ãþ 101-103È£) 08:00~08:30 Sensitive, Simple, and Scalable BCR-ABL Monitoring Justin T Brown(Principal Scientist Asuragen)

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room A (1Ãþ 101-103È£) 09:00~09:22 EP06, Á¤·®Àû ÃøÁ¤ÀýÂ÷ÀÇ Á÷¼±¼º Æò°¡ Á¶ÁÖ¿µ(¿¬¼¼¿øÁÖÀÇ´ë)

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room A (1Ãþ 101-103È£) 09:22~09:44 AUTO15, °Ë»çºÐ¾ßº° Áø´Ü°Ë»ç °á°ú ÀÚµ¿°ËÁõ ¹Ú°Ç(Á¶¼±ÀÇ´ë)

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room A (1Ãþ 101-103È£) 09:44~10:06 H60, ·çǪ½ºÇ×ÀÀ°íÀÎÀÚ °Ë»ç½Ç °Ë»ç;½ÂÀÎ Áöħ ¼Õ¿ëÇÐ(¾¾Á¨ÀÇ·áÀç´Ü)

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room A (1Ãþ 101-103È£) 10:06~10:30 QMS05, ¼öŹ°Ë»ç½ÇÀÇ ÀÚ°Ý, ¼±Åà ¹× Æò°¡ ³ë°æÈ£(±¹¹Î°Ç°­º¸Çè Àϻ꺴¿ø)

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room A (1Ãþ 101-103È£) 12:00~12:30 Overview and available data on high specific and highly sensitive TMA assays for hepatitis and HIV detection and therapy monitoring Paul Grant(Professor HSL London)

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room A (1Ãþ 101-103È£) 13:00~13:25 º¸°ÇÀÇ·á ºòµ¥ÀÌÅÍ È°¿ë¹æ¾È ¹ÚÁ¾Çå(°Ç°­º¸Çè°ø´Ü ºòµ¥ÀÌÅͿ½Ç)

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room A (1Ãþ 101-103È£) 13:25~13:50 °Ç°­º¸Çè ºòµ¥ÀÌÅÍ È°¿ëÀÇ ½ÇÁ¦ Á¶±ÝÁØ(°í·ÁÀÇ´ë »êºÎÀΰú)

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room A (1Ãþ 101-103È£) 13:50~14:15 Áø´Ü°Ë»ç Ç°Áú°ú ¾Ï °ËÁø °á°ú: °ø´Üµ¥ÀÌÅÍ ºÐ¼® ±èÇü¼ö(°Ç±¹ÀÇ´ë ¿¹¹æÀÇÇб³½Ç)

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room A (1Ãþ 101-103È£) 14:15~14:40 ºòµ¥ÀÌÅÍ È°¿ë ½Ã Áø´Ü°Ë»ç °á°ú Ç°ÁúÀÇ Á߿伺 ±è¼ÖÀÙ(¿ï»êÀÇ´ë)

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room B (1Ãþ 106-108È£) 08:00~08:30 A Way TLA System should be: MPAM+ system applied in GC labs ¾È¼±Çö(GC³ì½ÊÀÚÀÇ·áÀç´Ü)

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room B (1Ãþ 106-108È£) 09:00~09:30 Áø´Ü°Ë»ç ÀûÁ¤¼º°ü¸®¿¡ ´ëÇÑ Á¦¾È Á¶¿µÇý(ºÎ»êÀÇ´ë °¡Á¤ÀÇÇаú)

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room B (1Ãþ 106-108È£) 09:30~10:00 ±¹¿Ü ÇöȲ ¹× Ÿ °¡À̵å¶óÀÎ °ËÅä ¹®¼ö¿µ(µ¿±¹ÀÇ´ë)

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room B (1Ãþ 106-108È£) 10:00~10:30 Áø´Ü°Ë»çÀûÁ¤¼º °¡À̵å¶óÀÎ ¹× »ç·Ê ¼Ò°³ À̼±¹Î(ºÎ»êÀÇ´ë)

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room B (1Ãþ 106-108È£) 12:00~12:30 Real-Time PCR BCR-ABL Quantification ±è¸í½Å(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room B (1Ãþ 106-108È£) 13:00~13:30 ¸Ó½Å·¯´×°ú µö·¯´×ÀÇ ¿¬±¸ È°¿ë °æÇè ÀÌ´©¸®(ÇѸ²ÀÇ´ë)

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room B (1Ãþ 106-108È£) 13:30~14:00 ELISA ¹× À¯¼¼Æ÷°Ë»ç¸¦ ÀÌ¿ëÇÑ ¸é¿ª ¹ÙÀÌ¿À¸¶Ä¿ ¹ß±¼ ¿¬±¸ °æÇè À¯Àº°æ(ÀÎÁ¦ÀÇ´ë)

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room B (1Ãþ 106-108È£) 14:00~14:30 DOAC ³óµµ ÃøÁ¤ÀÇ ½ÇÁ¦ ±èÇý¸²(ºÎ»êÀÇ´ë)

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room B (1Ãþ 106-108È£) 15:00~15:30 ³í¹® Åõ°í±ÔÁ¤¿¡ ¸Â´Â Ç¥, ±×¸² ÀÛ¼º ³ëÇÏ¿ì ±èµµ±Õ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room B (1Ãþ 106-108È£) 15:30~16:00 ¿¬±¸¸¦ À§ÇÑ R ÇÁ·Î±×·¡¹Ö ¾ð¾îÀÇ ¼Ò°³ ¹× È°¿ë À±Àç¿ø(Áß¾Óº¸Èƺ´¿ø º¸ÈÆÀÇÇבּ¸¼Ò)

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room B (1Ãþ 106-108È£) 16:00~16:30 R ÇÁ·Î±×·¡¹Ö ¾ð¾î·Î Figure ¸¸µé±â ¹ÚÇØÀÏ(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room C (2Ãþ APECȦ) 11:00~12:00 Precision oncology: Where are we now, and where are we going? Jason D. Merker(University of North Carolina)

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room C (2Ãþ APECȦ) 12:00~12:30 ´ÙÁß È£Èí±â ÇöÀåºÐÀÚÁø´Ü°Ë»çÀÇ ÀÓ»óÀû À¯È¿¼º ÀÌÁ¾À±(ºÎ»êÀÇ´ë)

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room C (2Ãþ APECȦ) 13:00~13:30 ¿µÀ¯¾Æ¿Í ³ëÀο¡¼­ Ç÷¾×°Ë»ç Âü°íÄ¡¿Í À̽´ ÀÌ¿µ°æ(ÇѸ²ÀÇ´ë)

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room C (2Ãþ APECȦ) 13:30~14:00 ³ëÈ­¿Í Ç÷¾×Áúȯ ½Å¸í±Ù(Àü³²ÀÇ´ë)

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room C (2Ãþ APECȦ) 14:00~14:30 Imaging Flow Cytometry for Chromosome Detection in Blood Cancers Wendy N. Erber(The University of Western Australia)

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room C (2Ãþ APECȦ) 15:00~15:22 Àå±âÀ̽İ˻çÀÇ ÇöȲ ¹Ú±Ýº¸·¡(Çѱ¹Àå±âÁ¶Á÷±âÁõ¿ø)

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room C (2Ãþ APECȦ) 15:22~15:44 HLA NGS Çüº°°Ë»ç ¹× eplet ºÐ¼® ¹æÇØÀÎ(¼øõÇâÀÇ´ë)

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room C (2Ãþ APECȦ) 15:44~16:06 Non-HLA Ç×ü ¹ÚÀ±Èñ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room C (2Ãþ APECȦ) 16:06~16:30 ½ÅÀåÀ̽Ŀ¡¼­ ±âÁõÀÚ ¼¼Æ÷À¯¸® ÇÙ»ê (DD-cfDNA) °Ë»ç ¿ÀÀºÁö(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room D (2Ãþ 201-204È£) 12:00~12:30 Productivity and efficiency with STA-Workcell Max Yip.Hadison(Support business director STAGO)

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room D (2Ãþ 201-204È£) 13:00~13:22 Á¤¹ÐÀǷḦ À§ÇÑ µ¿¹ÝÁø´Ü°Ë»çÀÇ ÇöȲ ±èº¸¶÷(»ï±¤ÀÇ·áÀç´Ü)

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room D (2Ãþ 201-204È£) 13:22~13:44 MassARRAYÀÇ È°¿ë ¼ÕÁö¿¬(ÀÌ¿øÀÇ·áÀç´Ü)

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room D (2Ãþ 201-204È£) 13:44~14:06 Ç÷¾×³» Á¾¾çDNA °Ë»ç°æÇè°ú ÇöÁÖ¼Ò ÀÌÁÖ¿ø(¼­¿ïÀÇ°úÇבּ¸¼Ò)

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room D (2Ãþ 201-204È£) 14:06~14:30 ¾ËÃ÷ÇÏÀÌ¸Ó À§Çèµµ °Ë»ç, Alzon ±è¼öÇö(¾¾Á¨ÀÇ·áÀç´Ü)

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room D (2Ãþ 201-204È£) 14:30~15:00 Ä«¹ÙÆä³Û³»¼ºÀå³»¼¼±Õ¼Ó±ÕÁ¾ÀÇ ¿ªÇÐÀÇ º¯È­ º¯Á¤Çö(°æ»óÀÇ´ë) Çʼö

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room D (2Ãþ 201-204È£) 15:00~15:30 Ä«¹ÙÆä³Û³»¼ºÀå³»¼¼±Õ¼Ó±ÕÁ¾ °Ë»ç¹ý ¿øÀºÁ¤(¿ï»êÀÇ´ë) Çʼö

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room D (2Ãþ 201-204È£) 15:30~16:00 Ä«¹ÙÆä³Û³»¼ºÀå³»¼¼±Õ¼Ó±ÕÁ¾ ºÐÀÚ¿ªÇаú À¯ÇàÁ¶»ç ÀÌÇõ¹Î(¿¬¼¼ÀÇ´ë) Çʼö

±³À°½Ã°£ 04¿ù 28ÀÏ BEXCO ÄÁº¥¼ÇȦ Room D (2Ãþ 201-204È£) 16:00~16:30 Ä«¹ÙÆä³Û³»¼ºÀå³»¼¼±Õ¼Ó±ÕÁ¾ °¨¿°ÁõÀÇ Ä¡·á Á¤¿ëÇÊ(¿ï»êÀÇ´ë °¨¿°³»°ú) Çʼö

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ 2023 Ãá°è½ÉÆ÷Áö¾ö(2ÀÏÂ÷) : 2023-04-28""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ë±¸°æºÏÁöȸ Çѱ¹½Å»ý¾ÆÀü¹®¼Ò»ý¼ú(KNALS) Provider °úÁ¤ ½Ç±â±³À° : 2023-04-29
´ÙÀ½±Û ¼¼°èÀ¯¹æ¾ÏÇмú´ëȸ 2023 ¹× Çѱ¹À¯¹æ¾ÏÇмú´ëȸ (GBCC 2023) (2ÀÏÂ÷) : 2023-04-28
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21060 ¿ï»ê ´ëÇÑ»êºÎÀΰúÀÇ»çȸ ¿ï»êÁöȸ ¿¬¼ö±³À°(¿ù°æÅë, µ¥³ë¼ö¹ä Áß´Ü ÈÄ ¹Ýµ¿°ñÀýÀÇ ¿¹¹æ) : 2024-07-04 0 4 2024-06-18
21059 ¼­¿ï (¿Â¶óÀÎ)¹ÙÀÌ¿Àºòµ¥ÀÌÅÍÀÇ È°¿ë°ú ÃֽŠ¿ªÇÐ ¼³°è ¹× ±â°èÇнÀ(3ÀÏÂ÷) : 2024-07-03 0 1 2024-06-18
21058 °æ±â 2024³â ÆòÅýÃÀÇ»çȸ ÇÏ°èÇмú´ëȸ : 2024-07-02 0 8 2024-06-18
21057 ¼­¿ï ¿Â¶óÀÎ)¹ÙÀÌ¿Àºòµ¥ÀÌÅÍÀÇ È°¿ë°ú ÃֽŠ¿ªÇÐ ¼³°è ¹× ±â°èÇнÀ(2ÀÏÂ÷) : 2024-07-02 0 4 2024-06-18
21056 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-01 0 2 2024-06-18
21055 ¼­¿ï (¿Â¶óÀÎ)¹ÙÀÌ¿Àºòµ¥ÀÌÅÍÀÇ È°¿ë°ú ÃֽŠ¿ªÇÐ ¼³°è ¹× ±â°èÇнÀ(1ÀÏÂ÷) : 2024-07-01 0 3 2024-06-18
21054 ÃæºÏ ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ Understanding Current Community Mental Health and Emotional Disorders in ASD : 2024-07-01 0 6 2024-06-18
21053 ¼­¿ï (¿Â¶óÀÎ) 2024³âµµ °³¿øÀÇ ½ÉÆ÷Áö¾ö : 2024-06-30 0 6 2024-06-18
21052 °æ±â ´ëÇÑÁ¤ÇüÅëÁõÀÇÇÐȸ - Á¦2ȸ CHAMS °³¿øÀÇ ½ÉÆ÷Áö¾ö : 2024-06-30 0 8 2024-06-18
21051 ¼­¿ï 2024³â ´ëÇÑ°¡Á¤ÀÇÇÐȸ ¼­¿ïÁöȸ Çϰ迬¼ö°­Á : 2024-06-30 0 8 2024-06-18
21050 ºÎ»ê 2024³â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ºÎ¿ï°æÁöȸ ¿¬¼ö°­Á : 2024-06-30 0 12 2024-06-18
21049 ¼­¿ï Á¦26Â÷ ´ëÇѾƵ¿º´¿øÇùȸ Ãá°èÇмú´ëȸ : 2024-06-30 0 5 2024-06-18
21048 Ãæ³² 2024 ÀÌ°úÇÐ ¿¬±¸¼¼¹Ì³ª : 2024-06-29 0 5 2024-06-18
21047 ¼­¿ï ´ëÇѽÉÀåÈ£ÈíÀçÈ°ÀÇÇÐȸ Á¦14ȸ Çмú´ëȸ : 2024-06-29 0 9 2024-06-18
21046 ÀÎõ Á¦13Â÷ ÀÎõ½Ã³»°úÀÇ»çȸ Ãá°èÇмú´ëȸ : 2024-06-29 0 7 2024-06-18
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷